sodium salicylate has been researched along with sq-23377 in 1 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 4,385 | 10 | 493 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belia, S; Bertotto, A; Bistoni, O; Costantini, V; Fiorucci, S; Gerli, R; Gresele, P; Muscat, C; Paolucci, C | 1 |
1 other study(ies) available for sodium salicylate and sq-23377
Article | Year |
---|---|
Salicylates inhibit adhesion and transmigration of T lymphocytes by preventing integrin activation induced by contact with endothelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium; CD11 Antigens; CD18 Antigens; Cell Adhesion; Cell Division; Cells, Cultured; Chemotaxis, Leukocyte; Collagen; Cyclooxygenase Inhibitors; Cytokines; Depression, Chemical; Endothelium, Vascular; Humans; Integrin beta1; Interleukin-2; Ion Transport; Ionomycin; Ionophores; Macromolecular Substances; Sodium Salicylate; T-Lymphocytes; Umbilical Veins | 1998 |